|Day Low/High||104,74 / 107,51|
|52 Wk Low/High||92,06 / 127,34|
Leading growth stock experts highlight their best picks in the space.
The exploding field of 'payments' is reshaping how both consumers and businesses do transactions.
While it may be somewhat premature, we're getting several stock upgrades this afternoon: PetMed Express upgraded to Buy from Neutral at Sidoti with a $31 price target Douglas Dynamics at Sidoti to Buy from Neutral Fiserv by Atlantic Equities to Ove...
These funds invest in companies poised to benefit from millennial spending trends.
It is hard to find a sector of the economy that hasn't been touched by financial technology innovations.
While top and bottom line exceeded expectations, investors will be disillusioned by 1Q and 2019 fiscal year guidance. For a stock that has risen from $51 to $78 - there was little room for such a disappointment - and I expect the shares to fall by a...
Raymond James has downgraded Square : We are downgrading shares of SQ to Underperform from Market Perform and establishing a fair value estimate of $56, implying 27% downside. In short, we believe organic growth peaked in 3Q18 and growth on the all-...
Deals that simply were unworkable four months ago because of price are now being done with alacrity.
* I have sold my long position in Square and I have taken the stock off of my Best Ideas List This morning's announcement that Fiserv will acquire First Data has buoyed the shares of payments companies (with whom First Data and Fiserv compete with) ...
Straying from these names could land you in quicksand as the 4th quarter begins.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
I am opportunistically looking to add exposure to strong themes.
The bullish side dominates, with consumer cyclicals and energy names most prevalent.
Contrary to popular opinion, the so-called Fintech Revolution is not going to do away with traditional banking services.
Celgene shares are off 16 percent year-to-date and last week's weak guidance did not enthuse the biotech giant's backers.
Jim Cramer likes stock of Kohl’s after the company topped earnings estimates.
Facebook is the way of the future, according to Jim Cramer, co-manager of Action Alerts PLUS portfolio and host of CNBC’s ‘Mad Money.'
Some of the stocks listed here are rate hike winners.